Expert Review of Neurotherapeutics, Volume 24, Issue 8 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Neurotherapeutics, Volume 24, Issue 8 (2024)

See all volumes and issues
Volume 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?
Benedikt Reuter, Annemarie Miano, Josepha Wassermann & Björn Elsner
Pages: 723-726
Published online: 14 Jun 2024
First Page PreviewforWhy does exposure-based therapy fail in some individuals with obsessive-compulsive disorder? | Full Text | References | PDF (189.6 KB) | EPUB
  • 463 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Review Article
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents
Chesika J. Crump, Hagar Abuelazm, Kirolos Ibrahim, Shaishav Shah & Rif S. El-Mallakh
Pages: 727-733
Published online: 05 Jul 2024
AbstractforAn overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents | Full Text | References | PDF (321.1 KB) | EPUB
  • 154 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Special Report

Report
Mindfulness as a therapeutic option for obsessive-compulsive disorder
Andreas Reis, Marlon Westhoff, Hicham Quintarelli & Stefan G. Hofmann
Pages: 735-741
Published online: 18 Jun 2024
AbstractforMindfulness as a therapeutic option for obsessive-compulsive disorder | Full Text | References | PDF (237.7 KB) | EPUB
  • 447 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Giulio Emilio Brancati, Anna Magnesa, Donatella Acierno, Marco Carli, Ugo De Rosa, Alessandro Froli, Samuele Gemignani, Lisa Ventura, Francesco Weiss & Giulio Perugi
Pages: 743-759
Published online: 25 Jun 2024
AbstractforCurrent nonstimulant medications for adults with attention-deficit/hyperactivity disorder | Full Text | References | PDF (426.1 KB) | EPUB
  • 71 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder
Justin Faden, Camila Ramirez, Vanessa Martinez & Leslie Citrome
Pages: 761-771
Published online: 23 Jul 2024
AbstractforAn overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder | Full Text | References | PDF (315.7 KB) | EPUB
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
An update on pharmacotherapy for trigeminal neuralgia
Joseph V. Pergolizzi Jr, Jo Ann LeQuang, Salah N. El-Tallawy, Morgan Wagner, Rania S. Ahmed & Giustino Varrassi
Pages: 773-786
Published online: 13 Jun 2024
AbstractforAn update on pharmacotherapy for trigeminal neuralgia | Full Text | References | PDF (385.5 KB) | EPUB
  • 160 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Current use of neurotoxins for alleviating symptoms of cervical dystonia
Stephen Aradi & Robert A. Hauser
Pages: 787-797
Published online: 19 Jun 2024
AbstractforCurrent use of neurotoxins for alleviating symptoms of cervical dystonia | Full Text | References | PDF (1.5 MB) | EPUB
  • 14 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools
Luca Angelini, Giulia Paparella & Matteo Bologna
Pages: 799-814
Published online: 17 Jul 2024
AbstractforDistinguishing essential tremor from Parkinson’s disease: clinical and experimental tools | Full Text | References | PDF (394.7 KB) | EPUB
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, Pinelopi Papachristou, Dimitrios Rallis, Theodoros Karapanayiotides, Andreas Galanopoulos, Konstantinos Spingos, Nikolaos Dimisianos, Emmanouil Giakoumakis, Periklis Zavridis, Konstantinos Notas, George S. Vlachos, Panagiotis Soldatos, Konstantinos Bilias, Georgia Xiromerisiou, Jobst Rudolf, Emmanouil V. Dermitzakis & Alan M. Rapoport
Pages: 815-826
Published online: 13 Jun 2024
AbstractforPreferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints | Full Text | References | PDF (322.2 KB) | EPUB | Supplemental
  • 90 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder
Justin Faden et al.
Review Article | Published online: 23 Jul 2024
Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder
Joseph Blanco et al.
Review Article | Published online: 22 Jul 2024
Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation
Claudio Piqueras-Sanchez et al.
Review Article | Published online: 22 Jul 2024
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms
Abhishek Lenka et al.
Review Article | Published online: 21 Jul 2024
View all latest articles